Suppr超能文献

利用组织间液和微针技术革新治疗药物监测

Revolutionizing Therapeutic Drug Monitoring with the Use of Interstitial Fluid and Microneedles Technology.

作者信息

Kiang Tony K L, Ranamukhaarachchi Sahan A, Ensom Mary H H

机构信息

Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2E1, Canada.

Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.

出版信息

Pharmaceutics. 2017 Oct 11;9(4):43. doi: 10.3390/pharmaceutics9040043.

Abstract

While therapeutic drug monitoring (TDM) that uses blood as the biological matrix is the traditional gold standard, this practice may be impossible, impractical, or unethical for some patient populations (e.g., elderly, pediatric, anemic) and those with fragile veins. In the context of finding an alternative biological matrix for TDM, this manuscript will provide a qualitative review on: (1) the principles of TDM; (2) alternative matrices for TDM; (3) current evidence supporting the use of interstitial fluid (ISF) for TDM in clinical models; (4) the use of microneedle technologies, which is potentially minimally invasive and pain-free, for the collection of ISF; and (5) future directions. The current state of knowledge on the use of ISF for TDM in humans is still limited. A thorough literature review indicates that only a few drug classes have been investigated (i.e., anti-infectives, anticonvulsants, and miscellaneous other agents). Studies have successfully demonstrated techniques for ISF extraction from the skin but have failed to demonstrate commercial feasibility of ISF extraction followed by analysis of its content outside the ISF-collecting microneedle device. In contrast, microneedle-integrated biosensors built to extract ISF and perform the biomolecule analysis on-device, with a key feature of not needing to transfer ISF to a separate instrument, have yielded promising results that need to be validated in pre-clinical and clinical studies. The most promising applications for microneedle-integrated biosensors is continuous monitoring of biomolecules from the skin's ISF. Conducting TDM using ISF is at the stage where its clinical utility should be investigated. Based on the advancements described in the current review, the immediate future direction for this area of research is to establish the suitability of using ISF for TDM in human models for drugs that have been found suitable in pre-clinical experiments.

摘要

虽然以血液作为生物基质的治疗药物监测(TDM)是传统的金标准,但对于某些患者群体(如老年人、儿童、贫血患者)以及静脉脆弱的患者而言,这种做法可能无法实现、不切实际或不符合伦理道德。在寻找TDM替代生物基质的背景下,本手稿将对以下内容进行定性综述:(1)TDM的原理;(2)TDM的替代基质;(3)目前支持在临床模型中使用间质液(ISF)进行TDM的证据;(4)使用微针技术采集ISF,该技术可能具有微创和无痛的特点;(5)未来的发展方向。目前关于在人体中使用ISF进行TDM的知识仍然有限。全面的文献综述表明,仅对少数几类药物进行了研究(即抗感染药、抗惊厥药和其他各类药物)。研究已成功证明了从皮肤提取ISF的技术,但未能证明在ISF采集微针装置之外提取ISF并分析其成分的商业可行性。相比之下,用于提取ISF并在装置上进行生物分子分析的集成微针生物传感器,其关键特性是无需将ISF转移到单独的仪器上,已取得了有前景的结果,需要在临床前和临床研究中进行验证。集成微针生物传感器最有前景的应用是对皮肤ISF中的生物分子进行连续监测。使用ISF进行TDM正处于应研究其临床效用的阶段。基于当前综述中描述的进展,该研究领域近期的未来方向是确定在临床前实验中已被证明适用的药物,在人体模型中使用ISF进行TDM的适用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f225/5750649/2f02c44e24ed/pharmaceutics-09-00043-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验